Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Advanced Gastric or Gastro-Esophageal Cancers

EP. 1: Introduction and Global Trends of Gastric Cancer

July 18th 2019

EP. 2: Genetic Risk, Screening, and Diagnosis for Gastric Cancer

July 18th 2019

EP. 3: Molecular Testing Used for Gastric Cancer

July 18th 2019

EP. 4: Factors Determining Initial Treatment Approach for Gastric Cancer

July 18th 2019

EP. 5: Treatment in HER2-Positive Disease and Dosing Preferences

July 18th 2019

EP. 6: First-Line Therapy in HER2-Negative Gastric Cancer

July 18th 2019

EP. 7: Trastuzumab in HER2-Positive Gastroesophageal Cancer

July 18th 2019

EP. 8: Surgery Options in Locally Advanced Gastric Cancer

July 18th 2019

EP. 9: Differentiating Among the Types of Surgery

July 18th 2019

EP. 10: Place for Surgery and Poor Prognosis

July 18th 2019

EP. 11: Ramucirumab for Progressive Disease in Gastric Cancer

July 18th 2019

EP. 12: The Role of Immunotherapy in Gastric Cancer

July 18th 2019

EP. 13: Interpretation of Data on Immunotherapy Use in Gastric Cancer

July 18th 2019

EP. 14: Novel and Combination Therapies for the Treatment of Gastric Cancer

July 18th 2019

EP. 15: Drug Development and Final Thoughts

July 18th 2019
Advertisement
Advertisement

Trending on OncLive

1

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

2

Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026

3

First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL

4

FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer

5

Upcoming First-Line HER2-Positive Trials: ARTEMIDE-Gastric01, DESTINY-Gastric05, and HLX22

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us